Search

Search Results

• Endometriosis and ovarian cancer - what they have in common?

  Natalia Zarankiewicz, Katarzyna Kosz, Aleksandra Kuchnicka, Martyna Zielińska, Natalia Wolanin, Bogumiła Ciseł

  230-239

  2020-08-17
• Targeted therapy with Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of solid tumours

  Faustyna Piędel, Agata Agnieszka Rocka, Klaudia Daria Szumna, Dominika Katarzyna Madras, Patryk Piotr Jasielski

  133-139

  2020-03-27
• Neoadjuvant chemotherapy for IIIC stage ovarian cancer - case report

  Aleksandra Obuchowska, Arkadiusz Standyło, Alicja Ozga, Justyna Wójcik, Karolina Obuchowska, Paweł Skorupski

  84-91

  2020-09-04
• Key trends in morbidity and mortality rate due to ovarian cancer in Ukraine

  M. Romaniv, N. Terenda

  138-145

  2023-05-31
• PARP Inhibitors in the Treatment of Ovarian Cancer a review of the latest research

  Andrzej Paweł Zuzak, Małgorzata Satora, Magdalena Cieślik-Porębska, Krzysztof Kułak, Jagoda Niewiadomska

  57677

  2025-02-21
• The latest reports on biomarkers used in the diagnosis of ovarian cancer

  Aleksandra Chałupnik, Zuzanna Chilimoniuk, Maciej Dobosz, Anna Sobstyl, Małgorzata Sobstyl

  799-809

  2022-08-02
• Diagnostic challenges in the diagnosis and treatment of ovarian cancer in Lynch syndrome

  Agnieszka Protasiuk, Agata Żak, Rafał Sierzpowski, Patrycja Tymoszuk, Bartosz Kasperek, Katarzyna Augustowska

  56840

  2025-01-03
• Fertility Preservation Strategies in Cancer Patients: A Comprehensive Review

  Michał Razik, Piotr Bator, Patrycja Rozwadowska, Jan Ramian, Jakub Rybak, Barbara Magiera, Karol Magiera, Wiktor Razik

  129-139

  2024-02-19
• The role of soy in development of breast, ovarian, endometrial and prostate gland cancer

  Marcela Maksymowicz, Piotr Machowiec, Natalia Baran, Małgorzata Piekarska

  180-186

  2021-09-11
• Роль гомеостатистических механизмов в формировании результативности платинолечения больных с раком яичника = Role homeostatistic mechanisms in the formation of performance platinum treatment of patients with ovarian cancer

  A. I. Rybin

  405-414

  2016-06-17
• Ketogenic diet for ovarian disorders - promising nutritional approach in polycystic ovarian syndrome and ovarian cancer

  Magda Wojtuś, Sebastian Tomaszuk, Karolina Wąsik

  49846

  2024-04-12
• Mechanisms of drug resistance in ovarian cancer

  Klaudia Żak, Michał Piwoński, Paweł Stanicki, Karolina Kalicka, Justyna Nowaczek

  362-367

  2021-09-21
• Роль цикла оксида азота в формировании особенностей течения рака яичника = Role of nitrogen oxide cycle in the formation features of the current ovarian cancer

  A. Ribin

  399-404

  2015-11-25
• Особенности процессов детоксикации у больных раком яичника с разной чувствительностью к препаратам платины = Features detoxification process ovarian cancer patients with different sensitivity to platinum drugs

  A. I. Ribin

  686-690

  2015-12-31
• Current ideas about molecular genetic subtypes of ovarian cancer: a personalized approach and a new platform for further research

  A. Rybin

  157-168

  2021-11-26
• An overview of endometrial cancer risk factors

  Piotr Żychoń , Eryk Prajwos , Kamil Janawa, Michał Tomaszek , Małgorzata Domagała, Klaudia Cękalska, Wiktoria Stenka

  56569

  2024-12-20
• Risk factors of ovarian cancer: family history, obesity and oral contraceptive use

  Aleksandra Amalia Kuchnicka, Martyna Zielińska, Natalia Zarankiewicz, Katarzyna Kosz, Halina Piecewicz-Szczęsna

  397-402

  2020-09-18
• Sexuality and fertility of young women suffering from breast cancer

  Martyna Zielińska, Natalia Zarankiewicz, Katarzyna Kosz, Aleksandra Kuchnicka, Jakub Aleksandrowicz, Katarzyna Książek, Sylwia Mojsym-Korybska

  775-785

  2019-08-02
• Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer

  A. I. Rybin, V. Y. Maksymovskyj, V. V. Pyrogov, R. Ya. Demidchik, A. O. Varabina

  412-417

  2018-10-31
• Selected effects of combined oral contraceptives use

  Julia Bogucka, Anna Brzyska, Natalia Domańska, Małgorzata Bojarska, Natalia Wilczek, Halina Piecewicz-Szczęsna

  259-272

  2022-08-31
• Vitamin A - potential anticancer weapon

  Natalia Aleksandra Popławska, Justyna Śliz, Marta Skorupska, Magdalena Joanna Czeczotka, Krzysztof Woźniak

  51511

  2024-05-30
• The quality of life of patients with ovarian cancer as an indicator of functional assessing the effectiveness of anticancer therapy

  O. O. Kolesnik, A. I. Rybin

  539-551

  2017-05-31
• Synchronous borderline ovarian tumor with endometrioid endometrial carcinoma - from diagnosis to treatment. A Case study

  Eliza Kolasa, Alicja Paluch, Krzysztof Kułak

  48-58

  2023-06-21
• Clinical differentiation between ovarian granulosa cell tumor and ovarian cancer: a review

  Małgorzata Chyćko, Julia Czarnota, Katarzyna Cichoń, Nina Lasota, Maciej Lambach, Martyna Younes, Gabriela Demidowicz, Wojciech Wiśniewski, Klaudia Kowalczyk, Natalia Trąbka

  105-113

  2023-10-27
• The Modern Approaches and Future Perspectives on Breast and Ovarian Cancer Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers: A Literature Overview

  Sandra Sarnacka, Jakub Kordialik, Julia Koćwin, Paula Bieganek, Bartosz Sadłowski, Stanisław Łukaszewicz, Piotr Pawłowski, Julia Rybak, Michał Tokarski, Angelika Banasiak

  49454

  2024-05-16
• Modern strategies of platinum resistance overcoming in patients with the serous ovarian cancer

  Andriy Rybin

  594-599

  2018-11-30
• Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation

  Anna Rodzajewska, Weronika Kuryło, Katarzyna Szklener

  138-147

  2023-08-08
• Ovarian tumors - epidemiology, diagnosis and prevention in Poland

  Agata Ulenberg, Grzegorz Ulenberg

  299-310

  2018-11-16
• Endometriosis and an increased risk of malignancies

  Aleksandra Maria Krasa, Magdalena Kozioł, Halina Piecewicz-Szczęsna, Mateusz Pawlicki, Anna Łopuszyńska, Paulina Krawiec, Ewa Piekarska

  290-298

  2020-09-12
• Clinical significancy of WNT pathway inhibition in various cancers

  Patryk Rogaczewski, Michał Janiak , Kamil Borysewicz, Tadeusz Głos, Navid Ahmadi, Łukasz Szylberg

  183-191

  2022-11-03
• Results of treatment of cancer patients with peritoneal carcinomatosis

  O. Bondar, A. Rybin, A. Varabina

  304-314

  2022-05-31
• Have thyroid hormones an impact on ovarian cancer?

  Klaudia Żak, Sylwiusz Niedobylski, Milena Leziak, Karolina Maliszewska, Mirella Czapska, Katarzyna Skórzyńska-Dziduszko

  803-809

  2018-12-31
• TIMP way to stop metastasis?

  Katarzyna Jarosz, Robert Chudzik, Maria Gołębiowska, Beata Gołębiowska

  598-604

  2017-08-03
• Bisophosphonates in the treatment of osteoporosis in women with breast cancer

  Joanna Wolska

  357-363

  2019-09-09
• Endometriosis: Pathogenesis, diagnosis, treatment and the role of gut microbiota

  Hanna Senat, Patrycja Grabowska, Aleksandra Senat, Patrycja Bolla, Aleksandra Madej, Zuzanna Marczyńska, Karolina Libracka

  87-101

  2024-02-13
• Pathogenetic substantiation of a differential approach to the treatment of endometrial hyperplasia in women with abdominal obesity

  Nataliia Mokrianyn

  60415

  2025-04-18
• Anticancer properties of berberine - analysis of the latest reports

  Patrycja Rozwadowska, Piotr Bator, Michał Razik, Jan Ramian, Jakub Rybak, Barbara Magiera, Karol Magiera, Wiktor Razik

  73-86

  2024-02-16
• Hyaluronic acid in gynecology and obstetrics

  Anna Małgorzata Łopuszyńska, Łukasz Ochyra, Mateusz Pawlicki, Halina Piecewicz-Szczęsna

  335-340

  2022-04-30